Hugo G. B. Nijmeijer

Hugo G. B. Nijmeijer

Auto-generated profile, based on publicly available information

Hugo G. B. Nijmeijer

Department of Otorhinolaryngology, Radboud University Medical Center

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2020 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
HNHugo G. B. Nijmeijer
Hugo G. B. Nijmeijer
NKNoud M. Keijsers
Noud M. Keijsers
WHWendy J. Huinck
Wendy J. Huinck
EMEmmanuel A. M. Mylanus
Emmanuel A. M. Mylanus
Purpose: This scoping review examines the available evidence on the effect of unilateral cochlear implantation (CI) in adults with postlingual bilateral hearing loss on societal-related outcomes in terms of work, autonomy and participation. Methods: Five databases were searched (Pubmed, Web of Science, Embase, PsycINFO and Cochrane Library). Publications were screened in three steps on inclusion criteria. Of the 4230 screened publications, 110 met the inclusion criteria and were assessed for data extraction regarding outcomes “work”, “autonomy”, “participation”. Study characteristics and key findings are presented and narratively described. Results: Twenty-seven publications were included and categorized into retrospective (n = 3), cross-sectional (n = 18) or prospective (n = 6) study designs. Measurement or identification of number of outcomes (no) were related to work (no = 20), participation (no = 9) and autonomy or independency (no = 10). Most studies indicated benefits of CI on these outcomes. However, some studies did not or indicated additional barriers for benefits. Eleven publications primarily aimed to study one or more of our primary outcomes. Conclusion: In this literature search, scientific databases are reviewed. The results indicate that there is a relatively small body of evidence regarding the effect of CI on the outcomes “work”, “autonomy” and “participation”. Even though there are some limitations of the current study including some overlap in outcome definitions, most included studies indicate a beneficial effect of CI on work, autonomy and participation. The lack of consensus in definitions and the small body of evidence indicates a need for additional prospective studies investigating the societal outcomes of CI in postlingually deafened adults.

26 January 2025 in International Journal of Audiology
Verified
Journal Article
Open access
NPNikki Philpott
Nikki Philpott
HNHugo G. B. Nijmeijer
Hugo G. B. Nijmeijer
BPBirgit Philips
Birgit Philips
MKMarre W. Kaandorp
Marre W. Kaandorp
JFJohan HM Frijns
Johan HM Frijns
WHWendy J. Huinck
Wendy J. Huinck
To assess the impact of cochlear implantation (CI) and speech perception outcomes on the quality of life (QoL) of adult CI users and their communication partners (CP) one-year post-implantation. This research is part of a prospective multicenter study in The Netherlands, called SMILE (Societal Merit of Intervention for hearing Loss Evaluation). Eighty adult CI users completed speech perception testing and the Nijmegen Cochear Implant Questionnaire (NCIQ). Fifty-four CPs completed the Hearing Impairment Impact - Significant Other Profile (HII-SOP). CI resulted in a large improvement in the QoL of both users and CPs. Despite this, some users still reported difficulties in the NCIQ sub-domains Social Interactions, Activity Limitations and Self-esteem. Similarly, some CPs still reported moderate and severe third-party disability on the HII-SOP. Additionally, the correlation between speech perception results and self-reported QoL was weak to negligible for both groups. Speech perception in quiet is not an accurate measure of real-life success with a CI. A subset of CI users and CPs still experience substantial QoL challenges regardless of speech perception performance. To improve counselling and intervention, QoL measures should be a standard part of the CI care pathway for CI users and their CPs.

6 July 2022 in The Laryngoscope
Verified
Journal Article
Open access
HNHugo G. B. Nijmeijer
Hugo G. B. Nijmeijer
HGHans M. M. Groenewoud
Hans M. M. Groenewoud
EMEmmanuel A. M. Mylanus
Emmanuel A. M. Mylanus
AGAndré Goedegebure
André Goedegebure
WHWendy J. Huinck
Wendy J. Huinck
GWGert Jan van der Wilt
Gert Jan van der Wilt
Objectives: Eligibility criteria for cochlear implantation (CI) are shifting due to technological and surgical improvements. The aim of this study was to explore the impact of further expanding unilateral CI criteria in those with severe hearing loss (HL) (61–80 dBHL) in terms of number of CI recipients, costs, quality of life, and cost‐effectiveness.Methods: A dynamic population‐based Markov model was constructed mimicking the Dutch population in three age categories over a period of 20 years. Health states included severe HL (61–80 dBHL), profound HL (>81 dBHL), CI recipients, and no‐CI recipients. Model parameters were based on published literature, (national) databases, expert opinion, and model calibration.Results: If persons with severe HL would qualify and opt for CI similar to those with profound HL now, this would lead to a 6–7 times increase of new CI recipients and an associated increase in costs (€550 million) and QALYs (54.000) over a 20‐year period (incremental cost utility ratio: 10.771 euros/QALY [2.5–97.5 percentiles: 1.252–23.171]). One‐way‐sensitivity analysis indicated that model outcomes were most sensitive to regaining employment, utility associated with having a CI, and costs of surgery and testing.Conclusion: Our findings suggest that expanding eligibility for CI to persons with severe HL could be a cost‐effective use of resources. Clearly, however, it would require a significant increase in diagnostic, operative, and rehabilitative capacity. Our quantitative estimates can serve as a basis for a wider societal deliberation on the question whether such an increase can and should be pursued.Level of Evidence: NA Laryngoscope, 133:924–932, 2023

27 June 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
HNHugo G B Nijmeijer
Hugo G B Nijmeijer
WHWendy J Huinck
Wendy J Huinck
SKSophia E Kramer
Sophia E Kramer
ADA Rogier T Donders
A Rogier T Donders
GWGert Jan van der Wilt
Gert Jan van der Wilt
EMEmmanuel A M Mylanus
Emmanuel A M Mylanus
Introduction Cochlear implantation (CI) is a (cost-)effective intervention for people with severe or profound hearing loss. Since its introduction experience increased and the technology evolved, leading to better results and relaxation of CI eligibility criteria. Meanwhile, with national healthcare costs increasing there is a need for evidence of healthcare technology’s value. This protocol describes a study to investigate clinical and participatory outcomes after CI for the currently (expanded) eligible hearing impaired population. The study adds to the current evidence base through its multicentre design, long-term follow-up and use of participatory outcomes alongside standard clinical outcomes. Methods This multicentre prospective observational cohort study will include at least 156 adult patients with severe-to-profound hearing loss, approximately evenly divided into two groups (1, ages 18–65 years and 2, age >65 years). The measurements consist of audiometry, cognition tests, listening effort tests and multiple generic and disease specific questionnaires. Questionnaires will be administered twice before CI, soon after inclusion at CI referral and shortly before CI surgery, with an annual follow-up of 3 years after CI. The Impact on Participation and Autonomy questionnaire will be used to assess participation. Generalised models (linear, logistic, Poisson) will be used. Mixed effects models will be used to investigate changes over time while exploring differences in subgroups and the influence of covariates. Ethics and dissemination The study has received ethical approval from the Medical Ethical Committee of all participating centres. The results could provide valuable insights into changes in participatory outcomes of people with severe-to-profound hearing loss after CI. Results will be disseminated through peer-reviewed journals, scientific conferences and professional and patient organisation meetings. Trial registration number NCT05525221.

26 September 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
HNHugo G.B. Nijmeijer
Hugo G.B. Nijmeijer
NPN. Philpott
N. Philpott
GWGj van der Wilt
Gj van der Wilt
ADA. R.T Donders
A. R.T Donders
EGE. George
E. George
EME. A.M. Mylanus
E. A.M. Mylanus
Introduction: Various factors, including an aging population and expanding eligibility criteria, may increase the demand for cochlear implants (CIs), potentially resulting in longer waiting times. In most Dutch CI centers, the time between referral and surgery exceeds 6 months. Clinical experience suggests that during the waiting period for cochlear implantation, hearing and communication difficulties increase. Simultaneously, there is an interest in outcomes more closely aligned with patient values and needs, which resulted in the SMILE (Societal Merit of Interventions on hearing Loss Evaluation) study. This paper presents results on observed changes in societal and participatory outcomes during waiting time in participants with a time to CI surgery exceeding 6 months. Methods: SMILE is a prospective multi-center study including 232 individuals who were referred for unilateral CI. Continuous and nominal data from multiple questionnaires, sent immediately after referral and shortly before surgery, were analyzed by computing differences, Cohen’s D, and odds ratios. Results: Of the total 232 participants, 102 had a time between inclusion and surgery exceeding 6 months. Of these, 89 had (partially) filled out surveys at both time points. Of all the domain scores 55% did not show differences between timepoints. All Cohen’s D estimates were relatively small, ranging from − 0.298 to 0.388 for those outcomes that showed noteworthy changes. Conclusion: Waiting time from referral to surgery, even though exceeding 6 months, was observed to not seriously affect non-clinically-prioritized patients in an adverse way. Future investigations should identify subgroups on tolerable waiting times regarding short- and long-term outcomes. Trial registration: Trial registration number at ClinicalTrials.gov: NCT05525221, 25-8-2022.

8 November 2026 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
ASAmrita Kim Singh
Amrita Kim Singh
LJLindy Janse
Lindy Janse
NPNikki Philpott
Nikki Philpott
HNHugo G. B. Nijmeijer
Hugo G. B. Nijmeijer
EMEmmanuel A. M. Mylanus
Emmanuel A. M. Mylanus
WHWendy J. Huinck
Wendy J. Huinck